Table 2.

Proportion of patients with baseline T-scores < −2.7, <−3.0, and <−3.5 before and after PSW.

	Before balancing		After PSW
	Romo/DMAb (N = 3490)	DMAb/DMAb (N = 2952)	Romo/DMAb (N = 3490)	DMAb/DMAb (N = 2952)
BMD T-score, n (%)
Lumbar spine
<−2.7	1893 (54.24)	1557 (52.74)	1893 (54.24)	1593 (53.96)
<−3.0	1472 (42.18)	1224 (41.46)	1472 (42.18)	1257 (42.58)
<−3.5	798 (22.87)	689 (23.34)	798 (22.87)	720 (24.39)
Total hip
<−2.7	1127 (32.29)	899 (30.45)	1127 (32.29)	991 (33.57)
<−3.0	433 (12.41)	340 (11.52)	433 (12.41)	400 (13.55)
<−3.5	0 (0.00)	22 (0.75)	0 (0.00)	29 (0.98)

Abbreviations: DMAb = denosumab; PSW = propensity score weighting; Romo = romosozumab.